走向先进的再生疗法,以应对心脑血管疾病
Xi Chen1, Weiping Lin2,3, Micky Daniel Tortorella3,4
1Cardiovascular Research Institute & Department of Physiology, Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA.
概括
芯片上的血管化有机体为研究心血管和脑血管系统提供了一个与人类相关的模型. 这项技术推动了药物发现和个性化治疗,减少了对动物研究的依赖.
科学领域:
- 生物医学工程 生物医学工程
- 血管生物学 血管生物学
- 药物发现 药物发现 药物发现
背景情况:
- 血管化的有机体和器官芯片技术正在成为临床前研究的强大工具.
- 这些模型为研究复杂的生理系统提供了一个与人类相关的平台.
- 传统的动物模型在准确反映人类疾病和反应方面存在局限性.
研究的目的:
- 突出血管化芯片上的有机体在模拟人类心脑血管系统方面的潜力.
- 强调它们在推进个性化治疗和药物查方面的作用.
- 将这些系统作为临床前动物研究的替代品.
主要方法:
- 为心脑血管芯片模型开发集成的微流体系统.
- 使用器官芯片技术进行体外生理反应研究.
- 与先进技术的整合,如细胞和矩阵的三维生物打印.
主要成果:
- 芯片上的血管化器官提供了一个研究人类血管化的组织和器官的平台.
- 器官芯片技术促进了与药物查相关的体外生理反应.
- 这些系统为研究人类系统生物学提供了高度的人类基因组相关性.
结论:
- 血管化器官在芯片上的系统对于个性化治疗开发至关重要.
- 心脑血管芯片模型作为疾病研究中的动物研究的替代品.
- 与3D生物打印的整合可以使新药开发和个性化治疗策略成为可能.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
1.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
108
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
108
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
321
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321
Regulation of the Cardiovascular System
267
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
267
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
69
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
69


